Loomis, Sayles & Company
MDT icon

Loomis, Sayles & Company’s Medtronic MDT Stock Holding History

Loomis, Sayles & Company’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.4K Sell
801
-599
-43% -$57.4K ﹤0.01% 608
2025
Q4 		$134K Buy
1,400
+42
+3% +$4.08K ﹤0.01% 561
2025
Q3 		$129K Sell
1,358
-300
-18% -$27.6K ﹤0.01% 543
2025
Q2 		$145K Sell
1,658
-930
-36% -$78.9K ﹤0.01% 538
2025
Q1 		$233K Buy
2,588
+688
+36% +$61.6K ﹤0.01% 517
2024
Q4 		$152K Sell
1,900
-282
-13% -$24.4K ﹤0.01% 535
2024
Q3 		$196K Buy
2,182
+141
+7% +$11.9K ﹤0.01% 515
2024
Q2 		$161K Sell
2,041
-114
-5% -$9.35K ﹤0.01% 532
2024
Q1 		$188K Buy
2,155
+128
+6% +$10.9K ﹤0.01% 518
2023
Q4 		$167K Sell
2,027
-14
-0.7% -$1.07K ﹤0.01% 509
2023
Q3 		$160K Buy
2,041
+290
+17% +$24.3K ﹤0.01% 512
2023
Q2 		$154K Sell
1,751
-500
-22% -$43K ﹤0.01% 530
2023
Q1 		$181K Buy
2,251
+3
+0.1% +$245 ﹤0.01% 519
2022
Q4 		$175K Buy
2,248
+237
+12% +$19.2K ﹤0.01% 514
2022
Q3 		$162K Buy
2,011
+1,902
+1,745% +$171K ﹤0.01% 491
2022
Q2 		$10K Buy
109
+78
+252% +$7.9K ﹤0.01% 665
2022
Q1 		$3K Buy
+31
New +$3.27K ﹤0.01% 878
2021
Q1 		– Sell
-290
Closed -$34K – 869
2020
Q4 		$34K Sell
290
-25
-8% -$2.75K ﹤0.01% 576
2020
Q3 		$33K Sell
315
-174
-36% -$17.5K ﹤0.01% 570
2020
Q2 		$45K Sell
489
-10,984
-96% -$1.05M ﹤0.01% 546
2020
Q1 		$1.03M Buy
11,473
+8,294
+261% +$882K ﹤0.01% 448
2019
Q4 		$361K Sell
3,179
-16,609
-84% -$1.82M ﹤0.01% 510
2019
Q3 		$2.15M Buy
19,788
+8,260
+72% +$862K ﹤0.01% 468
2019
Q2 		$1.12M Buy
11,528
+10,107
+711% +$923K ﹤0.01% 485
2019
Q1 		$129K Sell
1,421
-60,192
-98% -$5.39M ﹤0.01% 546
2018
Q4 		$5.6M Sell
61,613
-133,894
-68% -$12.5M 0.01% 404
2018
Q3 		$19.2M Sell
195,507
-373,438
-66% -$34.5M 0.04% 226
2018
Q2 		$48.7M Sell
568,945
-199,819
-26% -$16.7M 0.1% 88
2018
Q1 		$61.7M Sell
768,764
-58,886
-7% -$4.86M 0.13% 75
2017
Q4 		$66.8M Sell
827,650
-127,392
-13% -$10.2M 0.14% 70
2017
Q3 		$74.3M Sell
955,042
-34,214
-3% -$2.84M 0.16% 62
2017
Q2 		$87.8M Sell
989,256
-103,281
-9% -$8.71M 0.21% 52
2017
Q1 		$88M Buy
1,092,537
+251,247
+30% +$19.6M 0.22% 54
2016
Q4 		$59.9M Buy
841,290
+92,907
+12% +$7.3M 0.15% 90
2016
Q3 		$64.7M Sell
748,383
-2,140
-0.3% -$186K 0.16% 72
2016
Q2 		$65.1M Sell
750,523
-39,361
-5% -$3.18M 0.18% 66
2016
Q1 		$59.2M Sell
789,884
-780
-0.1% -$58.7K 0.17% 83
2015
Q4 		$60.8M Buy
790,664
+1,738
+0.2% +$131K 0.17% 83
2015
Q3 		$52.8M Sell
788,926
-55,613
-7% -$4.1M 0.16% 98
2015
Q2 		$62.6M Sell
844,539
-52,427
-6% -$4.01M 0.17% 100
2015
Q1 		$70M Buy
896,966
+893,889
+29,051% +$67.8M 0.19% 96
2014
Q4 		$222K Sell
3,077
-407,896
-99% -$28.3M ﹤0.01% 632
2014
Q3 		$25.5M Buy
410,973
+10,593
+3% +$674K 0.07% 238
2014
Q2 		$25.5M Buy
400,380
+379,264
+1,796% +$23M 0.07% 265
2014
Q1 		$1.3M Buy
21,116
+335
+2% +$19.5K ﹤0.01% 577
2013
Q4 		$1.19M Sell
20,781
-1,071
-5% -$60.7K ﹤0.01% 617
2013
Q3 		$1.16M Sell
21,852
-248
-1% -$13.3K ﹤0.01% 604
2013
Q2 		$1.14K Buy
+22,100
New +$1.09M ﹤0.01% 591

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company's MDT Position: Q1 2026 in Review

Loomis, Sayles & Company reduced its Medtronic (MDT) stake by 43% in Q1 2026, selling an estimated $57.4K and leaving 801 shares worth $69.4K. The position accounts for ﹤0.01% of the portfolio, ranked #608.

Loomis, Sayles & Company first reported a position in MDT in Q2 2013 and has held it in 48 quarters since. The position peaked at $88M in Q1 2017. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Loomis, Sayles & Company held 801 shares of Medtronic worth $69.4K as of Q1 2026.
  • Loomis, Sayles & Company sold 599 Medtronic shares in Q1 2026, an estimated $57.4K.
  • Medtronic made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q1 2026, its #608 holding.
  • Loomis, Sayles & Company first reported a position in Medtronic in Q2 2013 and has held it in 48 quarters since.
  • Loomis, Sayles & Company's Medtronic position peaked at $88M in Q1 2017.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.